Epstein Secrets

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

t an agency source, when in fact, he was. 'I know nothing about Mr. Clinesmith other than what I've read,' Comey said." The Washington Times (9/30, Mordock, 492K) reports that Comey "admitted...that he wouldn't have signed the warrant application to wiretap former Trump campaign aide Carter Page. 'No.

ed pursuit of surveillance authority to track former Trump campaign adviser Carter Page, as part of the investigation." The Washington Times (9/30, Mordock, 492K) says Comey "took responsibility for what he described as 'embarrassing' errors the bureau made in the course of its investigation" into Page.

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

investigation." The Washington Times <https://www.washingtontimes.com/news/2020/sep/30/james-comey-i-am-responsible-embarrassing-carter-p/> (9/30, Mordock, 492K) says Comey "took responsibility for what he described as `embarrassing' errors the bureau made in the course of its investigation" into Page.

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ed pursuit of surveillance authority to track former Trump campaign adviser Carter Page, as part of the investigation." The Washington Times (9/30, Mordock, 492K) says Comey "took responsibility for what he described as 'embarrassing' errors the bureau made in the course of its investigation" into Page

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

ed pursuit of surveillance authority to track former Trump campaign adviser Carter Page, as part of the investigation." The Washington limes (9/30, Mordock, 492K) says Comey "took responsibility for what he described as 'embarrassing' errors the bureau made in the course of its investigation" into Page